The management of patients affected by moderate-to-severe psoriasis may be challenging,
in particular in patients with serious infectious diseases [tuberculosis (TB), hepatitis B and C …

Psoriasis is a systemic immune-mediated disease associated with an increased risk of
comorbidities, such as psoriatic arthritis, cardiovascular disease, metabolic syndrome …

Introduction In daily practice management of psoriasis, evaluation of risk factors for
infections is having a growing influence. Indeed, in psoriatic patients, risk of infections may …

Psoriasis is a common disease, which has a considerable impact on patients and the health
care system. Treatment approaches to the disease may be various because some issues …

Background: The management of HIV-positive patients with psoriasis is controversial and
limited to individual cases or short series of patients. Objectives: To evaluate the safety and …

Simple Summary Psoriasis is a chronic multisystem inflammatory disease associated with a
wide range of comorbidities including cardiovascular disease, hypertension, diabetes …

Opportunistic virus infections in psoriasis patients: the safer alternative of apremilast Page 1
Opportunistic virus infections in psoriasis patients: the safer alternative of apremilast Susana …

In recent years, there has been an increasing interest in developing new biologic treatments
for psoriasis. Ustekinumab, an interleukin (IL) IL12/IL23 inhibitor, has demonstrated real …

Considered more efficacious and safer than traditional systemic drugs, biologic therapies
have dramatically improved the quality of life of patients with psoriasis. Recently, there has …

Introduction Psoriasis is a chronic inflammatory skin disease often associated with several
comorbidities, such as psoriatic arthritis, inflammatory bowel disease, obesity, diabetes …